Börse:

SUMITOMO DAINIPPON PHARMA

[WKN: 858257 | ISIN: JP3495000006]

3,080€ 1,99%

Echtzeit-Aktienkurs SUMITOMO DAINIPPON PHARMA

Bid: Ask:

Nachrichten zur SUMITOMO DAINIPPON PHARMA Aktie

» Nachrichtenticker öffnen

Sumitomo Pharma Subsidiary Companies in the U.S., Including Sumitovant and its Wholly Owned Subsidiaries, to Combine and Form Sumitomo Pharma America

NEW YORK, April 3, 2023 /PRNewswire/ -- Sumitovant Biopharma Ltd. ("Sumitovant") announced today that its parent company Sumitomo Pharma Co.,…

Sumitomo Pharma Subsidiary Companies in the U.S., Including Sumitomo Pharma Oncology, to Combine and Form Sumitomo Pharma America

CAMBRIDGE, Mass., April 3, 2023 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., a wholly owned subsidiary of Sumitomo Pharma Co. Ltd,…

MYOVANT SCIENCES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Myovant Sciences - MYOV

NEW ORLEANS, Jan. 11, 2023 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law…

‹
1
›